Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
about
Redox mechanisms in hepatic chronic wound healing and fibrogenesisInsulin resistance in development and progression of nonalcoholic fatty liver diseaseGallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD miceRegressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat DietLipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cellsA review of iron studies in overweight and obese children and adolescents: a double burden in the young?Herbal adaptogens combined with protein fractions from bovine colostrum and hen egg yolk reduce liver TNF-α expression and protein carbonylation in Western diet feeding in ratsMitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.Oral branched-chain amino acid granules improve structure and function of human serum albumin in cirrhotic patientsMitochondrial DNA variants in the pathogenesis of type 2 diabetes - relevance of asian population studies.Intracellular calreticulin regulates multiple steps in fibrillar collagen expression, trafficking, and processing into the extracellular matrix.Kinetic assessment and therapeutic modulation of metabolic and inflammatory profiles in mice on a high-fat and cholesterol dietLipotoxicity in HepG2 cells triggered by free fatty acidsN-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitisSaturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway.Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistanceIdentification of liver proteins altered by type 2 diabetes mellitus in obese subjects.Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.Association between the PNPLA3 I148M polymorphism and non-alcoholic fatty liver disease in the Uygur and Han ethnic groups of northwestern China.Nonalcoholic Steatohepatitis: A Search for Factual Animal Models.Hepatic steatosis in obese patients: clinical aspects and prognostic significance.The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitisAssociation between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases.Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver diseaseEffect of Lipopolysaccharide on the Progression of Non-Alcoholic Fatty Liver Disease in High Caloric Diet-Fed Mice.The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease.Germinated brown rice ameliorates obesity in high-fat diet induced obese rats.Evaluation of antiobesity and cardioprotective effect of Gymnema sylvestre extract in murine model.High-sensitivity C-reactive protein and liver enzymes in individuals with Metabolic Syndrome in Talca, Chile.Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.Intermediate filament cytoskeleton of the liver in health and diseaseMitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion.Betaine supplement alleviates hepatic triglyceride accumulation of apolipoprotein E deficient mice via reducing methylation of peroxisomal proliferator-activated receptor alpha promoter.Relationship between Methyl Tertiary Butyl Ether Exposure and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Petrol Station Attendants in Southern China.Effect of GSTM1-Polymorphism on Disease Progression and Oxidative Stress in HIV Infection: Modulation by HIV/HCV Co-Infection and Alcohol Consumption.Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients.Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.Fibrogenesis in nonalcoholic steatohepatitis.Emerging drugs for non-alcoholic steatohepatitis.
P2860
Q24656684-4831619C-15AF-4F64-AD02-DFEFF42350D8Q26748687-48292493-2712-4718-9FA3-BEF68647C712Q27333713-93009BE5-5210-4F3D-AF54-7000679650F9Q28354293-226E631B-0A84-44EA-BADD-01134C954A8FQ28538284-A8686626-667A-4848-ACCC-3F72600E1A30Q30251906-73758B53-46E1-4A30-B32D-FD46A87667ADQ33597943-64C6620E-B10E-42E9-83DF-35BC8A9FBD3DQ33668501-2A722B33-669C-4D6A-A995-F580E88952CBQ33705346-3EA73ED3-16DA-4AFE-AB13-FF6ECCB74990Q33718097-418B4BED-2CB9-42E4-B756-FAA0FBC714A5Q33747983-1E98A2CB-3AA8-42F1-B5B0-CCAFCE7310E3Q33809501-06D8612C-1565-4249-83BB-260F3190A7C9Q33926763-3F083C7E-7EF5-4190-8316-E3AF003C1AD1Q34109325-34D24BD4-4516-475B-8ECE-5638F698B26DQ34128069-FC0D131D-08F6-4C1B-BA72-ABD565A907E6Q34137340-B1AC9A3B-3DFF-4DBE-9214-9E9C34B60571Q34160734-EB00FC05-61A3-4BF1-A0DE-5DD3B8174A36Q34279897-96674270-3A51-4DA1-A53B-192BC68D01CFQ34301321-23890E3F-74ED-47AF-A5E6-541ABB8D64E5Q35612535-76B15F5D-9DC9-46B5-9C8B-B1D8B4F5B3AAQ35669794-C9947BA6-B3B4-4704-9598-2A7C893C1B8CQ35761434-EC13BDE0-EC26-4AA8-AD43-A8B87A13E97CQ35777683-BD4B9928-F388-4259-B585-60CE468659C1Q35792208-5E8B1796-4A1F-4F6B-849F-030F875B61DAQ35829297-CA41C2B5-D91F-491E-809F-4CCA345A8E84Q35984078-AFAF8814-D388-49F3-80E1-834E730A0DD1Q36027467-89067739-9F1F-4626-8DFF-DE9FBAB2A41BQ36346113-440A91CA-45E3-4EAA-A8A0-A87076C8EF8FQ36375377-FAA9ACDE-7C7D-42A8-A58F-D29683BF4CD7Q36572087-56414408-E299-4061-B850-0E1BAD582C02Q36661678-0F22E8AE-FF71-40D2-810B-281455061CF7Q36704140-03A95A4E-F3A4-4E89-BFCE-D96F01518C31Q36753502-60370163-9587-4E75-93A7-51A0828455F2Q37379009-EADCD352-2B12-4851-830E-EC0E83C6D227Q37460405-E707C8F3-191B-49DA-8416-F05AD9AAF2C4Q37494299-18DB3360-7D1C-4D35-9E6A-E480725585E2Q37661014-C3D5B321-A994-475C-AA08-BBF5AC1E9FCDQ37731946-1C6417E8-2C98-4D7C-B48F-15BD86409EC4Q37863130-70012B23-C3E1-4B4C-8E7B-42A352A7A29DQ38121137-0B02C70D-4725-4F35-B109-8BB5AA207923
P2860
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@ast
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@en
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@nl
type
label
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@ast
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@en
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@nl
prefLabel
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@ast
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@en
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@nl
P2093
P1433
P1476
Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.
@en
P2093
David H Van Thiel
Kapil Mehta
Nikunj Shah
Sohrab Mobarhan
P304
P356
10.1301/002966402320387224
P577
2002-09-01T00:00:00Z